Medicare Enrolled

Dr. Susan Glenn, M.D.

Neurology · Raleigh, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1540 SUNDAY DR, Raleigh, NC 27607
9197823456
In practice since 2006 (20 years)
NPI: 1538191341 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Glenn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Glenn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Glenn

Dr. Susan Glenn is a neurology specialist in Raleigh, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Glenn performed 8,132 Medicare services across 876 unique beneficiaries.

Between the years covered by Open Payments, Dr. Glenn received a total of $1,635 from 35 pharmaceutical and/or device companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Glenn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 9% volume in NC $1,635 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,132
Medicare services
Top 9% in NC for neurology
876
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~407 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
MRI contrast dye injection (gadobutrol) 3,890 $0 $2
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg 3,080 $38 $90
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
496 $57 $150
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
106 $88 $220
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
76 $43 $180
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
62 $11 $100
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
62 $3 $15
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
50 $16 $166
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
48 $100 $380
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
43 $45 $228
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
39 $22 $90
MRI scan of brain, without contrast
A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves.
37 $88 $1,980
MRI of brain with and without contrast
An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures.
33 $154 $2,235
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
24 $84 $510
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
21 $43 $180
VEEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
19 $146 $800
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
17 $56 $266
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
16 $61 $160
MRI of upper spine without contrast
An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine.
13 $54 $1,518
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
89.7% medium
8.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,635
Total received (2018-2024)
Avg $234/year across 7 years
Top 43% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
80
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,505 (92.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$130 (7.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$285
2023
$200
2022
$91
2021
$183
2020
$109
2019
$401
2018
$367

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$100
ABBVIE INC.
$78
Novartis Pharmaceuticals Corporation
$43
Neurocrine Biosciences, Inc.
$19
Siemens Medical Solutions USA, Inc.
$19
Lilly USA, LLC
$14
Aucta Pharmaceuticals, Inc.
$13
Top 3 companies account for 77.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$271
Novartis Pharmaceuticals Corporation
$158
ABBVIE INC.
$156
BOSTON SCIENTIFIC CORPORATION
$123
Alexion Pharmaceuticals, Inc.
$114
GENZYME CORPORATION
$93
Allergan Inc.
$85
EMD Serono, Inc.
$48
Lundbeck LLC
$47
Biogen, Inc.
$41
Neurocrine Biosciences, Inc.
$37
Microtransponder, Inc.
$35
Merz North America, Inc.
$35
UCB, Inc.
$33
Teva Pharmaceuticals USA, Inc.
$27
GE HealthCare
$25
Grifols USA, LLC
$24
ARBOR PHARMACEUTICALS, INC.
$20
Avanir Pharmaceuticals, Inc.
$19
Amneal Pharmaceuticals LLC
$19
Siemens Medical Solutions USA, Inc.
$19
Mallinckrodt Enterprises LLC
$18
Janssen Pharmaceuticals, Inc
$17
Acorda Therapeutics, Inc
$17
Sunovion Pharmaceuticals Inc.
$17
Bausch Health US, LLC
$16
Upsher-Smith Laboratories LLC
$16
Allergan, Inc.
$14
Celgene Corporation
$14
AbbVie Inc.
$14
Lilly USA, LLC
$14
ACADIA Pharmaceuticals Inc
$13
Aucta Pharmaceuticals, Inc.
$13
PFIZER INC.
$12
Boston Scientific Corporation
$11
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BOTOX · BOTOX - NEUROLOGY · BOTOX - SPASTICITY · Biograph Vision 600 (8 Ring/64 CT) · Briviact · GENERAL DBS · GILENYA · Gamunex-C · General - Pain Management · Horizant · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · LYRICA · MIGRANAL · Mavenclad · Motpoly XR · NORTHERA · NUEDEXTA · NUPLAZID · Ongentys · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RYTARY · Rebif · SOLIRIS · SPINRAZA · UBRELVY · ULTOMIRIS · XEOMIN · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Raleigh?
Compare neurologists in the Raleigh area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
115
Per 100K population
10.0
County median income
$101,763
Nearest hospital
REX HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Glenn is a mixed practice specialist, with above-average Medicare volume (top 9% in NC), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Glenn experienced with mri contrast dye injection (gadobutrol)?
Based on Medicare claims data, Dr. Glenn performed 3,890 mri contrast dye injection (gadobutrol) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Glenn receive payments from pharmaceutical companies?
Yes. Dr. Glenn received a total of $1,635 from 35 companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Glenn's costs compare to other neurologists in Raleigh?
Dr. Glenn's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Glenn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →